Ανακοινώσεις εις την Ξένην
12th European Histocompatibility Conference Strasbourg, 25-27
March 1998, με την ανακοίνωση:
1 HLA associations in childhood acute lymphoblastic leukemia.
N.Constantinidou, Sophia Polychronopoulou, P.Georgi, J.P. Panagiotou,
O.Moraloglou, M.Kanariou, S.Haidas.
Dept. of Pediatric Hematology – Oncology and Lab. of Immunology and
Histocompatibility, “Aghia Sophia” Children’s Hospital. Athens –
HELLAS.
Combined Haematology Congress ISH-EHA, Amsterdam 4-8 July
1998 με τις ανακοινώσεις:
2
Primary and secondary myelodysplastic syndromes in childhood.
J.P.Panagiotou, Sophia Polychronopoulou, A.Parcharidou, V.Papadakis,
D.Anagnostou, S.Haidas.
Dept. of Pediatric Hematology – Oncology “Aghia Sophia” Children’s
Hospital and Dept. of Hematopathology Evangelismos Hospital – Athens,
HELLAS.
3
Aplastic anemia in childhood : Report of 28 cases.
Sophia Polychronopoulou, J.P.Panagiotou, V.Mikraki, S.Kostaridou,
M.Antoniadis, S.Haidas.
Dept. of Pediatric Hematology – Oncology ,“Aghia Sophia” Children’s
Hospital. Athens – HELLAS.
4
Mini and microsatelite instability in childhood acute lymphoblastic
leukemia (ALL).
Hatzaki, K. Stamatopoulos, Sophia Polychronopoulou, J..P. Panagiotou,
S.Haidas, D. Loukopoulos.
First Department of Medicine, University of Athens, “Laikon”General
Hospital and Dept. of Pediatric Hematology – Oncology ,“Aghia Sophia”
Children’s Hospital. Athens – HELLAS.
2nd International Symposium on Childhood MDS– Hindsgavl Castle,
Funen, Denmark, May 11-14, 2000 με τις ανακοινώσεις:
5
Myelodysplastic syndromes (MDS) in childhood : Clinical a
laboratory data of 23 patients.
Sophia Polychronopoulou, J.P.Panagiotou, L.Kossiva, K.Sambani,
K.Tsitsikas, D.Anagnostou, S.Haidas.
Dept. of Pediatric Hematology – Oncology “Aghia Sophia” Children’s
Hospital and Dept. of Hematopathology Evangelismos Hospital – Athens,
HELLAS.
6
Treatment and outcome of 23 paediatric patients with
myelodysplastic syndromes (MDS).
Sophia Polychronopoulou, J.P.Panagiotou, V.Papadakis, A.Parcharidou,
H.Psiachou, A.Mavrou, S.Haidas.
Dept. of Pediatric Hematology – Oncology “Aghia Sophia” Children’s
Hospital
XXXII SIOP Meeting, Amsterdam, The Netherlands, 4-7 October 2000,
με τις ανακοινώσεις:
7
Nasopharyngeal carcinoma of childhood and its association with
Epstein-Barr virus (EBV).
S.Kostaridou, Sophia Polychronopoulou, K.Stefanaki, L.Florentin,
J.P.Panagiotou, C.Constantinidou, G.Christopoulos, S.Haidas.
Dept. of Pediatric Hematology – Oncology “Aghia Sophia” Children’s
Hospital
8
Myelodysplastic syndromes (MDS) in childhood: Report of 23 cases.
Sophia Polychronopoulou, J.P.Panagiotou, L.Kossiva, K.Sambani,
K.Tsitsikas, D.Anagnostou, S.Haidas.
9
Results of a modified BFM-ALL 90 protocoll in acute lymphoblastic
leukaemia of childhood.
J.P.Panagiotou, Sophia Polychronopoulou, E.Vrachnou, S.Kostaridou,
V.Mikraki, M.Kanariou, S.Haidas.
10
Treatment of childhood ALL, with a ΒFM-based protocol in one
institution. Toxicity, compliance, and early results.
V.Mikraki, V.Papadakis, A.Parcharidou, J. P. Panagiotou, Sophia
Polychronopoulou, E.Psiachou-Leonard, M.Antoniadis, M.Kanariou,
S.Haidas.
42nd Annual Meeting of American Society of Hematology, December
1-5, 2000, με τις ανακοινώσεις :
11
Lymphocyte subpopulation disturbances during chemotherapy for
pediatric acute lymphoblastic leukemia (ALL).
S.Kostaridou, Sophia Polychronopoulou-Androulakaki, J.P.Panagiotou,
K.Psarra, V.Kapsimali, K.Tsagraki, P.Katevas, C.Papasteriadis, S.Haidas.
Dept of Pediatric Hematology / Oncology, “Aghia Sophia” Children’s
Hospital, Dept of Immunology and Histocampatibility, “Evangelismos”
Hospital, Athens-Greece.
12
Primary and secondary myelodysplastic syndromes (MDS) in
childhood.
Sophia Polychronopoulou-Androulakaki, J.P.Panagiotou, L.Kossiva,
M.Fameli, A.Mavrou, A.Kolialexi, K.Tsitsikas, K.Sambani, A.Stefanidou,
Y.Gyftodimou, D.Anagnostou, S.Haidas.
Dept of Pediatric Hematology / Oncology, “Aghia Sophia” Children’s
Hospital, Lab of Hematopathology, “Evangelismos” Hospital, Lab of
Cytogenetics of the 1st Pediatric Clinic of Athens University, “Aghia
Sophia” Children’s Hospital, Lab of Cytogenetics “Demokritos” Research
Center, Dept of Genetics, Institute of Child Health, Athens-Greece.
12th Annual Meeting (BSHI) 26th-28th September 2001, Cambridge, με
την ανακοίνωση:
13
HLA-DR, DQ polymorphism in childhood acute lymphoblastic
leukemia.
Sophia Polychronopoulou, K.Spanou, J.P.Panagiotou, A.Chaidaroglou,
P.Markantonatos, S.Haidas, N.Constantinidou
Dept. of Immunology-Histocompatibility, Dept. of Haematology / Oncology
– “Aghia Sophia” Children’s Hospital, Immunology Laboratory, “Onassio”
Cardiac Surgery Center, Athens, Greece .
BEST OVERSEAS ABSTRACT.
6th International Symposium on Myelodysplastic Syndromes,
Stockholm, Sweden 14-17 June, 2001, με την ανακοίνωση:
14
Problematic aspects in bone marrow biopsies of childhood MDS.
D. Anagnostou, Sophia Poluchronopoulou, A. Tasidou, M. Fameli, J.P.
Panagiotou, S.A. Haidas.
Hematopathology Dept., Evangelismos General Hospital, Department of
Pediatric Hematology / Oncology, «Aghia Sophia» Children’s Hospital,
Athens, Greece.
15th European Histocompatibility Conference, Granada, Spain 27th30th March 2001, με την ανακοίνωση:
15
HLA-Class II alleles in childhood acute lymphoblastic leukemia.
N.Costantinidou, Sophia Polychronopoulou, K.Spanou, J.P.Panagiotou,
A.Chaidaroglou, P.Markantonatos, M.Kanariou, S.Haidas.
Dept. of Immunology-Histocompatibility, Dept. of Haematology / Oncology
– “Aghia Sophia” Children’s Hospital, Immunology Laboratory “Onassio”
Cardiac Surgery Center, Athens, Greece.
AMERICAN SOCIETY OF HAEMATOLOGY (ASH), 43rd ANNUAL
MEETING DECEMBER 7-11, 2001, ORLANDO, FLORIDA, USA, με τις
ανακοινώσεις:
16
Immunophenotypic Study of Normal Calla Positive B Lymphocytes
(Hematogones) in Children’s Marrow Enables the Formulation of a
Strategy for the Assessment of Minimal Residual Disease (MRD) in BCell Precursor Acute Lymphoblastic Leukemia (Bprec-ALL).
G. Paterakis, S. Polychronopoulou, V. Rouli, J.P. Panagiotou, K.Kourendi,
D. Skoumi, C.Stavropoulou-Gioka, S.A. Haidas.
Laboratory of Immunology “G. Gennimatas” General Hospital, Department
of Pediatric Hematology / Oncology, “Aghia Sophia” Children’s Hospital,
Athens, Greece.
Abst. #1333, Blood 98 (11), part 1, p.316a, 2001.
17
Disease Characteristics and Course of Myeloproliferative Disorders
(MPDs) in Childhood.
S. Polychronopoulou, S. Kostaridou, J. P. Panagiotou, V. Rouli,
A.Parcharicou, C. Sambani, A. Tassidou, D. Anagnostou, S.A. Haidas.
Department of Pediatric Hematology / Oncology, “Aghia Sophia” Children’s
Hospital, N.C.S.R. “Democritos”, Department of Haematopathology,
“Evangelismos” Hospital, Athens, Greece.
Abst. #4858, Blood 98 (11), part 2, p.280b, 2001.
18
Trisomy 8 in Hematologic Malignancies: Recognition of the Common
Clinico-Hematologic Features from 76 patients. A Study of the Hellenic
MDS Study Group.
Symeonidis, K. Sabanis, T. Galanopoulos, N. Viniou, A. Parcharidou, E.
Terpos, A. Kouralis, T. Marinakis, N. Giannakoulas, E. Thanopoulou, P.
Roussou, K. Tsatalas, N. Laoutaris, A. Lazaridou, S. Polychronopoulou, M.
Protopappa, N. Zoumbos.
Hematology Division, Dept. of Internal Medicine, University of Patras
Medical School, Patras, Laboratory of Cytogenetics, “Demokritos” National
Research Institute, Athens, Hematology, “G. Gennimatas” General Hospital,
Athens, 1st Dept. of Internal Medicine, “Laikon” General Hospital, Athens,
Pediatrics, “St. Sofia” Pediatric Hospital, Athens, Hematology 251 Military
Airforce Hospital, Athens, Greece, 3rd Dept. of Internal Medicine “Sotiria”
General Hospital, Athens, Dept. of Hematology, Demokritos University of
Thrace, Alexandroupolis, Dept. of Hematology, St. Panteleimon General
Hospital, Athens, Dept. of Internal Medicine, Theagenion General Hospital,
Thessaloniki, Dept. of Internal Medicine, General Hospital of Serres, Serres,
GREECE
Abst. #4294, Blood 98 (11), part 2, p.155b, 2001.
19
Acute Megakaryocytic Leukemia in Children Associated with the
Presence of Hematogones.
Parcharidou, S. Labropoulos, G. Paterakis, S. Polychronopoulou, J.P.
Panagiotou, V. Papadakis, E. Psiachou-Leonard, H. Kosmidis, S. Haidas.
Hematology-Oncology, A.G. Sofia Children’s Hospital, Athens, HematologyOncology, Medical College of Virginia, Richmond, VA, USA, Immunology, G.
Gennimatas General Hospital, Athens, Hematology - Oncology, AG.
Kuriakou Children’s Hospital, Athens, Greece.
Abst. #4529, Blood 98 (11), part 2, p.205b, 2001.
American Society of Hematology (ASH), 44th Annual Meeting,
December 6-10, 2002, Philadelphia, Pensylvania, με την ανακοίνωση:
20
Interphase Fluorescence In-Situ Hybridization (FISH) Study of
Childhood B-cell Precurson Accute lymphoblastic Leukemia (B-ALL)
with normal karyotype.
S.I. Papadimitriou, Sophia Polychronopoulou, G.S. Paterakis, A.A.
Tsakiridou, I. Gligori, J.P. Panagiotou, A. Parcharidou, V. Papadakis, S.A.
Haidas, A. Tassiopoulou.
Hematology Laboratory «G. Gennimatas», Athens Regional General
Hospital, Department of Pediatric Hematology / Oncology, «Aghia Sophia»
Children’s Hospital, Immunology Laboratory, «G. Gennimatas» Athens
Regional General Hospital, Athens, Greece.
Blood, vol.100(11), Nov;16, p:189b, 2002 (Abst. No 4255).
7th International Symposium on Myelodysplastic Syndromes, MDS
2003, 15-18 May 2003, Paris, France, με την ανακοίνωση:
21
Reduced risk of leukemic transformation and prolonged survival for
patients with hypoplastic myelodysplastic syndromes (MDS)
Symeonidis, , A. Kouraklis-Symeonidis, Sophia Polychronopoulou, V.
Pappa, T. Galanopoulos, A. Parharidou, M. Karakantza, P. Matsouka, N.
Zoumbos.
University of Patras Medical School, Athens, Greece.
Η ανωτέρω ανακοίνωση περιελήφθη στο Τόμο Πρακτικών του
Συνεδρίου.
15th European Immunology Congress (EFIS 2003), 8-12 June 2003,
Rhodes island, Greece, με την ανακοίνωση:
22
Are CALLA (CD10+) B lymphocytes in cord and peripheral blood
derived from bone marrow normal B cell precursors (hematogones).
G. Paterakis, K. Kourendi, K. Papasaradi, D. Skoumi, Sophia
Polychronopoulou, I.P. Panagiotou, S. Haidas, A. Stavropoulos-Giokas.
Immunology Department “G. Gennimatas” General Hospital, Section of
Pediatric Hematology-Oncology “Agia Sophia” Hospital for Children, Athens,
Greece.
Η ανωτέρω ανακοίνωση περιελήφθη στο Τόμο Πρακτικών του
Συνεδρίου.
The 8th Annual Congress of the European Hematology Association, 1215 June 2003, Lyon, France, με την ανακοίνωση:
23
Molecular cytogenetic screening in childhood B-lineage acute
lymphoblastic leukemia (B-ALL) with normal karyotype.
S.I. Papadhimitriou, Sophia Polychronopoulou, A.A. Tsakiridou, I. Gligori,
G.S. Paterakis, J.P. Panagiotou, A. Davea, A. Parcharidou, V. Papadakis, C.
Politis, M. Georgiakaki.
G. Gennimatas”, Athens Regional General Hospital, “Aghia Sophia”
Children’s Hospital, Athens, Greece.
Η ανωτέρω ανακοίνωση περιελήφθη στο Τόμο Πρακτικών του
Συνεδρίου.
European Society of Clinical Microbiology and Infectious Diseases
(ESCMID), 10-13 May, 2003, Glascow, με την ανακοίνωση:
24
Etiology of septic episodes in children with haematologic malignancies
and solid tumors.
Charisiadou, J. Panagiotou, A. Doudoulakakis, A. Stamatiadou, Sophia
Polychronopoulou, A. Pangalis.
Departments of Clinical Microbiology and Paediatric Haematology Oncology,
“Aghia Sophia” Chlidren’s Hospital, Athens, Greece.
SIOP 2003, 8-11 October 2003, Cairo, Egypt, έχουν γίνει αποδεκτές προς
δημοσίευση oι ανακοινώσεις:
25
Frequency and type of positive blood cultures in pediatric patients
undergoing intensive ALL treatment in the presence of HICKMANBROVIAC catheter.
V. Papadakis, K. Katsimbardi, A. Parcharidou , J.P. Panagiotou, E.
Papandreou,Charisiadou, A. Pangalis, Sophia Polychronopoulou, S.Haidas.
Departments of Paediatric Haematology Oncology, and Microbiology, “Aghia
Sophia” Chlidren’s Hospital, Athens, Greece.
26
Frequency and type of infections during maintenance treatment in
pediatric patients with ALL.
K. Katsimbardi, V. Papadakis, J.P. Panagiotou, A.Parcharidou, M.Soutis,
Pangalis, Sophia Polychronopoulou, S.Haidas
Departments of Paediatric Haematology Oncology, and Microbiology, “Aghia
Sophia” Chlidren’s Hospital, Athens, Greece.
25th International Congress of Pediatrics, PP0369 2007
27
TESTICULAR MICROLITHIASIS IN TWO BROTHERS A DISTURBING
CLINICAL ISSUE
Dimitrios Thomas, Elpis Vlachopapadopoulou, Vassilios Papadakis,
Regina Sklavou, Michael Soutis, Sophia Polychronopoulou, Stefanos
Michalacos
25th International Congress of Pediatrics, PP0446
28
2007
EPIDEMIOLOGICAL DATA OF NEW PATIENTS WITH MALIGNANT
HEMATOLOGY-ONCOLOGY DIAGNOSES DURING THE YEAR 2005. A
HOLISTIC APPROACH OF ENSUING SOCIO-ECONOMIC ISSUES
Anna Paisiou, Vassilios Papadakis, Natalia Tourkantoni, Ioanna
Panaretaki, Sofia Delicou, Sofia Papargyri, AgapI Parcharidou, Sophia
Polychronopoulou
25th International Congress of Pediatrics, OP163a
2007
29
TEL/AML1+ ACUTE LYMPHOBLASTIC LEUKEMIA IN THE GREEK
PEDIATRIC POPULATION
Stefanos Papadhimitriou, Georgios S Paterakis, Agapi Parcharidou,
Anastasia Tsakiridou, Vassilios Papadakis, Sofia Papargyri, Anna
Paissiou, Natalia Tourkantoni, Konstantinos Tsitsikas, Dimitris Pavlidis,
Maria Georgiakaki, Sophia Polychronopoulou
25th International Congress of Pediatrics, 2007
30
EPIDEMIOLOGICAL DATA OF NEW PATIENTS WITH MALIGNANT
HEMATOLOGY-ONCOLOGY DIAGNOSES DURING THE YEAR 2005. A
HOLISTIC APPROACH OF ENSUING SOCIO-ECONOMIC ISSUES
Anna Paisiou, Vassilios Papadakis, Natalia Tourkantoni, Ioanna
Panaretaki, Sofia Delicou, Sofia Papargyri, Agap Parcharidoui, Sophia
Polychronopoulou
25th International Congress of Pediatrics, OP163b 2007
31
CLONAL HETEROGENEITY IN TEL/AML1+ ACUTE LYMPHOBLASTIC
LEUKEMIA (ALL): A CLINICAL APPRAISAL
Stefanos Papadhimitriou, Vassilios Papadakis, Anna Paissiou, Georgios
S Paterakis, Agapi Parcharidou, Anastasia A Tsakiridou, Konstantinos
Tsitsikas, Dimitris Pavlidis, Maria Georgiakaki, Sophia Polychronopoulou
25th International Congress of Pediatrics, PP0448 2007
32
OUTCOME OF HODGKIN'S LYMPHOMA IN CHILDREN DIAGNOSED
DURING 1997-2006
Sophia Parcharidou, Anna Paisiou, Vassilios Papadakis, Antonia Vlachou,
Sophia Papargyri, Calliopi Stefanaki, Sophia Delicou, Sophia
Polychronopoulou
25th International Congress of Pediatrics, PP0462
2007
33
CLINICAL AND LABORATORY INVESTIGATION OF CYTOPENIAS IN
CHILDREN : THE ROLE OF VIRAL INFECTIONS
Antonia Vlachou, Agapi Parcharidou, Rigina Sklavou, Vassilios
Papadakis, Sofia Papargyri, Nikolaos Spanakis, Nikolaos Legakis, Sophia
Polychronopoulou
25th International Congress of Pediatrics, PP0449 2007
34
CHARACTERISTICS, TREATMENT AND OUTCOME FOR
NEUROBLASTOMA PATIENTS
Vassilios Papadakis, Anna Paisiou, Michail Soutis, Spyridon Antypas,
Konstantinos Nikas, Demetrios Dimitriadis, Evaggelos Papandreou, Agapi
Parcharidou, Natalia Tourkantoni, Kalliopi Stefanaki, Sophia
Polychronopoulou
25th International Congress of Pediatrics, PP0450 2007
35
DEVELOPMENT OF SECONDARY OSTEOSARCOMA AFTER THE
TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA
Antonia Vlachou, Agapi Parcharidou, Rigina Sklavou, Vassilios
Papadakis, Elias Karanikas, Sophia Polychronopoulou
25th International Congress of Pediatrics, PP0451
36
2007
THERAPEUTIC RESULTS FOR NEPHROBLASTOMAS FOLLOWING
THE SIOP PROTOCOLS
Vassilios Papadakis, Antonia Vlachou, Rigina Sklavou, Anna Paissiou,
Natalia Tourkantoni, Kalliopi Stefanaki, Sophia Polychronopoulou:
25th International Congress of Pediatrics, OP133 2007
37
ONE CENTER EXPERIENCE ON MULTIPARAMETRIC MOLECULAR
DIAGNOSTIC APPROACH OF PEDIATRIC ACUTE LYMPHOBLASTIC
LEUKEMIA (ALL)
Agapi Parcharidou,Kostantinos Tsitsikas,Constantina Sambani,Stefanos
Papadhimitriou,George Paterakis,Chrisoula Belesi, Vassilios Papadakis,
Christiana Stavropoulou, Vasilios Georgakakos, Sophia Polychronopoulou
25th International Congress of Pediatrics, PP0453 2007
38
EXTENSIVE ARTERIOVENOUS DYSPLASIA OF THE INTESTINE , AS
A CAUSE OF SEVERE INFANTILE ANEMIA DUE TO RECURRENT
GASTROINTESTINAL BLEEDING
Natalia Tourkantoni , Vassilios Papadakis, Ioanna Panagiotou, Agapi
Parcharidou, Anna Paissiou, Rigina Sklavou, Antonia Vlachou, Eleftheria
Roma, Georgios Christopoulos-Geroulanos, Andreas Tzakis, Sofia
Polychronopoulou
25th International Congress of Pediatrics, PP0454 2007
39
CO-EXISTENCE OF MULTIPLE SUBCLONES TOGETHER WITH THE
TRANSLOCATION 12;21 (TEL/AML1) AT DIAGNOSIS IN CHILDHOOD
ACUTE LYMPHOBLASTIC LEUKEMIA
Agapi Parcharidou,Vassilios Papadakis, Vasilios Georgakakos, Christiana
Stavropoulou, Constantinos Tsitsikas, Constantina Sambani, Sophia
Polychronopoulou
25th International Congress of Pediatrics, OP134 2007
40
TWO DECADE EXPERIENCE AND LONG TERM SURVIVAL IN
PEDIATRIC NHL
Vassilios Papadakis, Agapi Parcharidou, Anna Paisiou, Natalia
Tourkantoni, Sofia Papargyri, Kalliopi Stefanaki, Sophia
Polychronopoulou
25th International Congress of Pediatrics, PP0456 2007
41
EVALUATION OF YEAR 2005 POSITIVE BLOOD CULTURES AND
SENSITIVITIES IN PEDIATRIC CANCER PATIENTS Vassilios
Papadakis, Anna Paisiou, John Christodoulou, Athina Charisiadis, Sofia
Papargyri, Constantinos Samantas, Natalia Tourkantoni, Agapi
Parcharidou, Anastasia Pangali, Sophia Polychronopoulou
25th International Congress of Pediatrics, PP0457 2007
42
SARCOMA TUMOR FAMILY IN CHILDHOOD: A 6 YEAR
EXPERIENCE IN SOFT TISSUE SARCOMA, EXTRA- AND
INTRAOSSEUS OSTEOSARCOMA
Natalia Tourkantoni, Anna Paissiou, Vassilios Papadakis, Antonia
Vlachou, Regina Sklavou, Sophia Polychronopoulou
25th International Congress of Pediatrics, PP0458 2007
43
LATE-APPEARING BCR/ABL IN A CASE OF ADOLESCENCE T-ALL
ASSOCIATED WITH HOMOZYGOUS INK4A DELETION
Vassilios Papadakis, Stefanos Papadhimitriou, Anna Paisiou,
Konstantinos Tsitsikas, Chrysoula Belesi, Agapi Parcharidou, Natalia
Tourkanton, Constantina Sambani, George Paterakis, Sophia
Polychronopoulou
25th International Congress of Pediatrics, PP0459 2007
44
AML1/ETO+ AML AFTER COMBINED TREATMENT FOR
EPENDYMOMA AND LONG EXPOSURE TO ETOPOSIDE: AN
ADOLESCENT CASE
Vassilios Papadakis, Stefanos I Papadhimitriou, Anna Paisiou, Agapi
Parcharidou, Natalia Tourkantoni, George Paterakis, Chrysoula Belesi,
Constantina Sambani, Sophia Polychronopoulou
25th International Congress of Pediatrics, PP0464 2007
45
ATYPICAL PRESENTATION OF METASTATIC EWING-SARCOMA
Vassilios Papadakis, Rigina Sklavou, Antonia Vlachou, Agapi Pacharidou,
Antonios Kourtesis, Kalliopi Stefanaki, Vasiliki Kitra, Sophia
Polychronopoulou
25th International Congress of Pediatrics, PP0465 2007
46
CORRELATION OF SERIALLY ESTIMATED CRP VALUES WITH THE
UNDERLYING INFECTIVE AGENT, DURING FEBRILE EPISODES, IN
PEDIATRIC ONCOLOGY PATIENTS
Rigina Sklavou, Vassilios Papadakis, Agapi Pacharidou, Maria Giannaki,
Antonia Vlachou, Sophia Delicou, Natalia Tourkantoni, Anna Paissiou,
Sophia Papargyri, Sophia Vasila, Sophia Polychronopoulou
11th International Conference of Thalassaemia and
Haemoglobinopathies, Singapore, Oct. 2008.
47
Study of Bone Density by pQCT Analysis in Healthy Adults and
Patients
with
β-Thalassemia
Major
and
Intermediate
V. Ladis, P. Raptou, E. Rigatou et al
14th Congress of the EHA (European Hematology Association), June
4-7-06/09, Berlin, Germany.
48
Efficacy, efficiency and safety for treating transfusional iron overload
in non actively transfused patients
A.Kattamis, N.Lazopoulou, E.Rigatou et al.
Excellence in Paediatrics” conference and the “Evidence Based
Medicine and Child Nutrition” scientific meeting, 3-6 December 2009,
Florence, Italy με τις ανακοινώσεις:
49
TREATMENT WITH RITUXIMAB OF CHILDREN AND ADOLESCENTS
WITH AUTOIMMUNE HEMATOLOGIC DISORDERS.
K. Roka, V. Papadakis,
K. Tsitsikas,
S. Papargyri,
G. Paterakis,
M.Ambatzidou, G. Avgerinou, E. Rigatou , S. Polychronopoulou
50
HAEMATOLOGICAL FEATURES OF CHILDHOOD NEUTROPENIA
G Avgerinou, K Roka, V Papadakis, E Rigatou, M Ambatzidou, E
Volonaki, K Tsitsikas, S Papargyri, Spolychronopoulou
15th Conference of the European Association of Haematology in
2010 με τις ανακοινώσεις:
51
Iron Distribution between Liver, Spleen, Pancreas, Bone marrow, and
Myocardium in β -Thalassemia Major: An R2-MRI study.
Ο.Papakonstantinou, N. Kelekis, Κ. Foufa, Α. Balanika. Ε Rigatou et al
52
Peripheral Quantitive Computed Tomography (PQCT) Study of the
functional muscle-bone unit in female patients with β -Thalassemia
Major
Ο.Papakonstantinou, Α. Balanika, C. Baltas, E.Rigatou et al
53
Tissue iron overload in multiple transfused patients with rare
anemias: An MR imaging study
Ο. Papakonstantinou, N. Kelekis, E. Rigatou et al
37th annual meeting of the European Group for Blood and marrow
transplantation Paris France 3-6 April 2011 με την ανακοίνωση:
54
Post transplant immune reconstitution after allogeneic stem cell
transplantation in paediatric patients with high risk leukemia.
E Rigatou, F. Gumy- Pause, V. Matiello, Y.Chalandon, M.Ansari,
H.Ozsahin
11th International Symposium of MDS Syndromes, Edinburgh, Uk,
May 18-21, 2011 με την ανακοίνωση:
55
Familial myelodysplastic Syndromes in children associated with
non-bone marrow failure congenital syndromes.
A.Makis, G. Avgerinou, S.I Papadimitriou K.Roka, E. Rigatou,
S.Polychronopoulou
MASCC/ISOO 2011 International Symposium, Athens, Greece 23-25
June, 2011 με την ανακοίνωση:
56
Fertility Issues Among Adolescents and Young Adult Cancer
Survivors
Sophia Polychronopoulou
7th European Course on Clinical Cytometry - 11th Euroconference on
Clinical Cell Analysis ESCCAA-IcyS, 13-17/09/2011, Dublin, Ireland
57
TAGONES, MINOR MATURE NK AND T LYMPHOCYTE
SUBPOPULATIONS INTERFERING WITH MRD T-ALL ANALYSIS - A
NOVEL STRATEGY PROPOSED
G.Paterakis, M.Ampatzidou, A.Taparkou, G.Avgerinou, Cl.Papassarandi,
D.Koliouskas, P.Vasileiou, S.Polychronopoulou
38th annual meeting of the European Group for Blood and marrow
transplantation Geneva Switzerland 1-4 April 2012 με τις
ανακοινώσεις:
58
Update in Post transplant immune reconstitution after allogeneic
stem cell transplantation in paediatric patients with high risk
leukemia.
E Rigatou, F. Gumy- Pause, V. Matiello, Y.Chalandon, M.Ansari,
H.Ozsahin
59
Diamond Blackfan anaemia: when to transplant?
E Rigatou, F. Gumy- Pause, V. Matiello, Y.Chalandon, M.Ansari,
H.Ozsahin
22nd International Congress on thrombosis, Nice, France, 6-9 October
2012 με την ανακοίνωση:
60
Severe thrombocytopenia and dilated superficial veins and
thrombosis: Infection, autoimmune disorder or LGL cytopenia?
E. Rigatou, G. Paterakis, H. Platokouki, K.Roka, G. Avgerinou,
V.Papadakis, S. Polychronopoulou
VI International Symposium of Myelodysplastic syndromes and bone
marrow failures in childhood Prague November 7-9 2012 με τις
ανακοινώσεις:
61
CLINICAL COURSE, TREATMENT AND OUTCOME OF CHILDREN
WITH MYELOPROLIFERATIVE NEOPLASMS (MPN): A
RETROSPECTIVE SINGLE CENTER REPORT
G.Avgerinou, S.Mouskou, M.Ampatzidou, A.Makis, V.Papadakis,
K.Tsitsikas, S.I.Papadhimitriou, K.Stefanaki, S.Polychronopoulou
62
HAEMATOLOGICAL FEATURES OF CHILDHOOD NEUTROPENIA
Georgia Avgerinou, Kleoniki Roka, Vassilios Papadakis, Efthymia Rigatou,
Maria Ambatzidou, Eleni Volonaki, Konstantinos Tsitsikas, Sophia
Papargyri and Sophia Polychronopoulou.
Child: care health and development,36: Suppl 1 Jan2010,pg74.
63
FAMILIAL OCURRENCE OF MYELODYSPLASTIC SYNDROME: A
REPORT OF 10 CASES
Makis2, G. Avgerinou1, S.I. Papadhimitriou3, E. Rigatou1, K. Manola4, K.
Stefanaki5 and S. Polychronopoulou1
64
Refractory cytopenia of Childhood: A retrospective study of 27
primary MDS cases from the Greek pediatric MDS registry
S. Polychronopoulou1, A. Makis2, S.I. Papadhimitriou3, G. Avgerinou1,
K.Tsitsikas, K. Stefanaki5 V. Papadakis,J.P.Panagiotou, K. Manola4,
E.Goussetis, G,Paterakis and S.Haidas
65
Long erm follow-up of children with aplasic anemia : a single center
experience
S. Polychronopoulou1, A. Makis2, G. Avgerinou1, J.P.Panagiotou,
A.Parcharidou, V. Papadakis, K.Tsitsikas, S.I. Papadhimitriou 3, K.
Stefanaki5 K. Manola4, S.Grafakos and S.Haidas.
“Excellence in Paediatrics” conference and the “Evidence Based
Medicine and Child Nutrition” scientific meeting, Florence, Italy με
την ανακοίνωση:
66
FAMILIAL MYELODYSPLASTIC SYNDROMES ( MDS ) IN CHILDREN
ASSOCIATED WITH NON- BONE MARROW FAILURE CONGENITAL
SYNDROMES
A.Makis, G.Avgerinou, S.I.Papadimitriou,K. Roka, E. Rigatou,
S.Polychronopoulou
44th Congress of the International Society of Pediatric Oncology
(SIOP) 2012, London.
67
Clinical course, treatment and outcome of children with
myeloproliferative neoplasms: a retrospective single center report
G. Avgerinou1, S.Mouskou, M.Ampatzidou, A. Makis2, V. Papadakis,
K.Tsitsikas, S.I. Papadhimitriou3, K. Stefanaki5 and S. Polychronopoulou1,
Padiatric Blood and Cancer,vol 59, Issue 6, December 1, 2012
68
PROGNOSTIC SIGNIFICANCE OF FLOW-CYTOMETRY MINIMAL
RESIDUAL DISEASE EVALUATION (FC-MRD) IN CHILDHOOD ACUTE
LYMPHOBLASTIC LEUKEMIA (ALL)
Maria Ampatzidou, George Paterakis, Vassilios Papadakis, Sophia
Papargyri, Stefanos I Papadhimitriou, Georgia Avgerinou, Efthymia
Rigatou, Stella Mouskou, Konstantinos Tsitsikas, Vassilios Vasdekis,
Sophia Polychronopoulou
69
TAGONES, MINOR MATURE NK AND T LYMPHOCYTE
SUBPOPULATIONS INTERFERING WITH MRD T-ALL ANALYSIS - A
NOVEL STRATEGY PROPOSED
G.Paterakis, M.Ampatzidou, A.Taparkou, G.Avgerinou, Cl.Papassarandi,
D.Koliouskas, P.Vasileiou, S.Polychronopoulou
Cytometry Part B (Clinical Cytometry), 80B: 390-429 (2011)
70
CONGENITAL LEUKEMIA CUTIS: BEYOND “BLUEBERRY MUFFIN”.
S.Mouskou, V. Papadakis, E. Rigatou, S. Polychronopoulou.
MASCC/ISOO 2012 International Symposium on Supportive Care in
Cancer, 28-30/6/2012, New York, USA με τις ανακοινώσεις:
71
Thyroid function evaluation in children diagnosed and treated for
childhood acute lymphoblastic leukemia
V. Papadakis, E.Vlachopapadopoulou,G. Avgerinou1,I.Barbalias S.
Papargyri and S. Polychronopoulou,PQ039
72
A New Look at Hypothyroidism, Dr.Drahomira Springer (Ed), ISBN:978953-51-0020, In Tech
73
Thyroid function following treatment of childhood Acute
Lymphoblastic Leukemia. (PP)
V. Papadakis, E.Vlachopapadopoulou,G. Avgerinou1,I.Barbalias S.
Papargyri and S. Polychronopoulou,
74
FAMILIAL MYELODYSPLASTIC SYNDROMES ( MDS ) IN CHILDREN
ASSOCIATED WITH NON- BONE MARROWFAILURE CONGENITAL
SYNDROMES
A.Makis, G.Avgerinou, S.I.Papadimitriou, K. Roka, E. Rigatou,
S.Polychronopoulou.
Leukemia Research, Volume 35, Suppl 1, May 2011, pp s109-110
75
CLINICAL VALUE OF FUNGAL SEROLOGY AND PCR IN THE
MANAGEMENT OF INVASIVE FUNGAL DISEASE (IFD) IN
PAEDIATRIC IMMUNOCOMPROMISED PATIENTS
Maria Ampatzidou, Aristea Velegraki, Marianna Varsami, S.
Antonopoulou, Sophia Papargyri, Vassilios Papadakis, Anastasia Pangali
and Sophia Polychronopoulou
17th Congress of EHA (European Hematology Association), 1417/6/2012, Amsterdam, The Netherlands με την ανακοίνωση:
76
TAGONES, MINOR MATURE NK AND T LYMPHOCYTE
SUBPOPULATIONS INTERFERING WITH MRD T-ALL ANALYSIS - A
NOVEL STRATEGY PROPOSED
G.Paterakis, A.Taparkou, M.Ampatzidou, G.Avgerinou, Cl.Papassarandi,
D.Koliouskas, P.Vasileiou, S.Polychronopoulou
ESCCA European Society of Clinical Cell Analysis, 13th
Euroconference on CLINICAL CELL ANALYSIS
12-14 November 2013, 9th European Course on CLINICAL
CYTOMETRY,15-16 November 2013 με την ανακοίνωση:
77
UNEXPECTED MLL REARRANGEMENTS IN ALL OF B-CELL ORIGIN,
WITH POSITIVE CYTOPLASMIC Μ AND LIGHT CHAIN RESTRICTION,
WITHOUT PRO-B PHENOTYPE
G. Paterakis, A. Taparkou, S.I. Papadhimitriou, A. Athanasiadou, M.
Ampatzidou, M. Kourti, D. Pavlidis, E. Farmaki, V. Papadakis, Ε.
Steiakaki, D. Koliouskas, S. Polychronopoulou.
9th Childhood Leukemia Symposium, 28-29 April 2014, Prague, Czech
Republic με τις ανακοινώσεις:
78
MLL REARRANGEMENTS IN CHILDHOOD ACUTE LYMPHOBLASTIC
LEUKEMIA : CLINICAL AND GENETIC FEATURES OF A DINSTICT
DISEASE ENTITY
Μ.Αmpatzidou, S.I.Papadhimitriou, L.Petrikkos, D.Pavlidis, Κ.Tsitsikas,
Ε.Rigatou, G.Paterakis and S.Polychronopoulou.
79
MLL REARRANGEMENTS IN CHILDHOOD ALL OF B-CELL ORIGIN
WITH NO PRO-B PHENOTYPE: ASSOCIATION WITH CYTOPLASMIC
Μ AND LIGHT CHAIN RESTRICTION
G. Paterakis, A. Taparkou, S.I. Papadhimitriou, A. Athanasiadou, M.
Ampatzidou, M. Kourti, D. Pavlidis, E. Farmaki, V. Papadakis, Ε. Stiakaki,
D. Koliouskas, S. Polychronopoulou.
80
ETV6/RUNX1-POSITIVE CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA
(ALL): DO ADDITIONAL ABERRATIONS INFLUENCE TREATMENT
RESPONSE AND OUTCOME?
Μ.Αmpatzidou, S.I.Papadhimitriou, G.Paterakis, Ε.Rigatou, L.Petrikkos,
D.Pavlidis, Κ.Tsitsikas, G.Vassilopoulos and S.Polychronopoulou.
Advances in Neuroblastoma Research Congress 2014, 13-16 May,
Cologne, Germany.
Clinical Research III
81
Myeloablative therapy (MAT) and Immunotherapy (IT) with
ch14.18/CHO for High-Risk Neuroblastoma: Update and News of
Randomised Results from HR-NBL1/SIOPEN trial. (OR067)
Ruth L Ladenstein, Ulrike Poetschger, Roberto Luksch, Penelope Brock, Victoria
Castel, Isaac Yaniv, Vassilios Papadakis, Genevieve Laureys, Josef Malis,
Walentyna Balwierz, Ellen Ruud, Per Kogner, Henrik Schroeder, Maja Beck
Popovic, Peter F Ambros, Guenter Schreier, Holger N. Lode, Hans Loibner, Andrew
DJ Pearson, Dominique Valteau Couanet; St. Anna Children's Cancer Research
Institute, Vienna, Austria; Istituto Nazionale Tumori di Milano, Milan, Italy; Great
Ormont Street Hospital, London, United Kingdom; Pediatric Hematology and
Oncology, Pediatric Oncology Unit Hospital La Fe Valencia, Valencia, Spain;
Schneider Children's Medical Center of Israel, Tel Aviv, Israel; Agia Sofia Children's
Hospital Athens, Athens, Greece; University Hospital Gent, Gent, Belgium;
University Hospital Motol, Prague, Czech Republic; Jagiellonian University Medical
College, Krakow, Poland; Rikshospitalet, Oslo, Norway; Karolinska Hospital,
Stockholm, Sweden; University Hospital of Aarhus, Skejby, Aarhus, Denmark;
Pediatric Hematology-Oncology Unit, University Hospital, Lausanne, Switzerland;
Children's Cancer Research Institute, St. Anna Kinderspital, Vienna, Austria; AIT
Austrian Institute of Technology GmbH, Graz, Austria; University Medicine
Greifswald, Greifswald, Germany; Apeiron Biologics, Vienna, Austria; Institute of
Cancer Research, Sutton, United Kingdom; Institut Gustave Roussy - Paediatric
and Adolescent Oncology Department, Villejuif, France
82
Genomic Profiling in Low and Intermediate Risk Neuroblastoma to
Refine Treatment Stratification and Improve Patient Outcome-LINES:
a SIOPEN Trial (POT095)
Gudrun Schleiermacher, Institut Curie, Department of Pediatric Oncology and
U830 INSERM, Paris, France; Raffaella Defferrari, Giannina Gaslini Institute,
Department of Pathology, Genoa, Italy; Katia Mazzocco, Giannina Gaslini
Institute, Department of Pathology, Genoa, Italy; Rosa Noguera, University of
Valencia, Department of Pathology, Valencia, Spain; Luigi Varesio, Giannina
Gaslini Institute, Laboratory of Molecular Biology, Genoa, Italy; Inge M.
Ambros, St. Anna Kinderkrebsforschung, Children’s Cancer Research
Institute, Vienna, Austria; Alain Bernheim, Gustave Roussy, Department of
Biology, Villejuif, France; Valerie Combaret, Centre Leon-Berard, Laboratoire
de Recherche Translationnelle, France; Marta Jeison, Schneider Children’s
Medical Center, Molecular Cytogenetique Laboratory, Israel; Nadine van Roy,
Ghent University Hospital, Center for Medical Genetics, Ghent, Belgium; Jean
Michon, Institut Curie, Department of pediatric Oncology, Paris, France;
Veronique Mosseri, Institut Curie, Department of Biostatistics, Paris, France;
Jose D. Bermudes, La Fe Hospital, Department of Biostatistics, Valencia,
Spain; Adela Canete, La Fe Hospital, Department of Pediatric Oncology,
Valencia, Spain; Andrea di Cataldo, University of Catania, Department of
Pediatric Oncology, Italy; Vassilios Papadakis, Aghia Sophia Children's
Hospital of Athens, Department of Pediatric Oncology, Greece; Kate Wheeler,
Oxford University Hospitals NHS Trust, Department of Pediatric Oncology,
United Kingdom; Peter F. Ambros, St. Anna Kinderkrebsforschung, Children’s
Cancer Research Institute, Vienna, Austria
83
Clinical Research: Phase 2 and 3 Trials
POC046
Influence of Age and Stage on Outcome in the High Risk
Neuroblastoma HR-NBL1/SIOPEN Trial
Ruth Ladenstein, St. Anna Children's Hospital and Research Institute,
Paediatric Haematology/Oncology, Vienna, Austria; Ulrike Poetschger, St
Anna Children's Hospital, Studies and Statistics on Integrated Research
and
Projects, Vienna, Austra; Roberto Luksch, Fondazione IRCCS
Istituto
Nazionale
Tumori
Haematology/Oncology, Milan,
di
Milano,
Italy; Penelope Brock, Great Ormond
Street Hospital, Paediatric Haematology/Oncology,
Kingdom; Victoria Castel, Hospital
Haematology/Oncology,
La
Fe
London,
Paediatric
Yaniv,
Schneider
Israel,
Paediatric
Haematology/Oncology, Israel; Vassilios Papadakis,
General
Paediatric Hospital, Paediatric
Belgium;
Athens
Haematology/Oncology,
Greece; Genevieve Laureys, University Hospital
Haematology/Oncology, Ghent,
United
Valencia,
Valencia, Spain; Isaac
Children's Medical Center of
Paediatric
Josef
Hospital Motol, Paediatric Haematology/Oncology,
Gent,
Paediatric
Malis,
University
Czech
Republic;
Walentyna Balwierz, Jagiellonia University Medical College, Paediatric
Haematology/Oncology, Krakow, Poland;
Paediatric Haematology/ Oncology,
Ellen
Ruud,
Oslo, Norway;
Karolinska Hospital, Paediatric Haematology/
Rikshospitalet,
Per
Oncology,
Kogner,
Stockholm,
Sweden; Henrik Schroeder, University Hospital of Aarhus, Skejby,
Paediatric
Haematology/Oncology, Aarhus, Denmark; Ana Forjaz De
Lacerda,
Portuguese
Haematology/Oncology,
Institute
Portugal;
of
Maja
Hospital, Paediatric Haematology/Oncology;
Oncology,
Paediatric
Beck-Popovic,
University
Pavel
University
Bician,
Children's Hospital, Paediatric Haematology/Oncology; Miklos Garami,
Semmelweis University,
Paediatric Haematology/ Oncology, Hungary;
Toby Trahair, Sydney
Children's
Hospital,
Paediatric
Haematology/Oncology, Sydney, NSW, Australia; Peter Ambros, St. Anna
Kinderkrebsforschung e.V., Tumour
Biology, Vienna, Austria; Keith
Holmes, St. George's Hospital, Paediatric
Surgery, London, United
Kingdom; Mark Gaze, University College London
Hospitals
NHS
Foundation Trust, Paediatric radiotherapy and radionuclide therapy,
London, United Kingdom; Cormac Owens, Our Lady's Children's
Hospital, Crumlin, Paediatric Haematology/Oncology, Dublin, Ireland;
Gunter
Schreier, Austrian Institute of Technology, Austria; Andy DJ
Pearson, Institute
Paediatric
of Cancer Research and Royal Marsden Hospital,
Haematology/Oncology,
Dominque Valteau- Couanet,
Haematology/Oncology,
84
Institut
London,
United
Kingdom;
Gustave
Roussy,
Paediatric
Villejuif, France
POC047
Non High-Risk Neuroblastoma European Strategy: SIOPEN LINES
Protocol Implementation, Challenges, and Achievements
Vanessa Segura, Instituto de Investigacion Sanitaria La Fe, Valencia, Spain;
Alisa Alspach, St Anna Children's Hospital, Children´s Cancer Research
Institute, Vienna, Austra; Andrea Di Cataldo, University of Catania, Pediatric
Hematology and Oncology, Italy; Gudrun Schleiermacher, Institut Curie,
Department of Pediatric Oncology, Laboratoire de Genetique et Biologie des
Cancers, Paris, France; Jose D Bermudez, Universidad de Valencia,
Departamento de Estadistica e Investigacion Operativa, Valencia, Spain;
Veronique Mosseri, Institut Curie, INSERM U, Laboratoire de Genetique et
Biologie des Cancers Paris, France; Vassilios Papadakis, Aghia Sophia
Children's Hospital, Department of Pediatric Hematology- Oncology, Greece;
Kate Wheeler, Oxford Children's Hospital, Department of Paediatric
Haematology and Oncology Oxford, United Kingdom; Victoria Castel, Instituto
de Investigacion Sanitaria La Fe, Grupo de Investigacion Clinica y
Traslacional en Cancer, Valencia, Spain; Massimo Conte, Giannina Gaslini
Children's Hospital, Department of Hematology-Oncology Genoa, Italy; Ruth
Ladenstein, St Anna Children's Hospital, Children´s Cancer Research
Institute, Vienna, Austria; Henrik Schroder, Aarhus University Hospital
Skejby, Aarhus, Denmark; Ann Sophie Defachelles, Centre Oscar-Lambret,
France; Dominique Plantaz, Hopital Michallon, Departement de pediatrie,
Grenoble, France; Sifrah Ash, Schneider Children's Medical Center of Israel,
Israel; Benedicte Brichard, University Hospital Leuven, Belgium; Adela
Canete, Polytechnic University La Fe, Pediatric Oncology Unit, Valencia,
Spain
56th Annual Meeting of the American Society of Hematology, San
Francisco, LA, 6-9 December 2014, με τις ανακοινώσεις
85
Flow-Cytometry MRD Evaluation in Children with ALL; Can MRD
Level on Day 33 Serve As a Surrogate Marker for Relapse?
Maria Ampatzidou, George Paterakis, Konstantinos Tsitsikas, Stephanos
I. Papadhimitriou, Vassilios Papadakis, Vassilios Vasdekis, Loizos
Petrikkos, and Sophia Polychronopoulou.
86
ETV6/RUNX1-Postitive Childhood Acute Lymphoblastic Leukemia
(ALL): Do Additional Aberrations Influence Treatment Response and
Outcome?
Maria Ampatzidou, Stephanos I. Papadhimitriou, George Paterakis, Loizos
Petrikkos, Dimitrios Pavlidis, Konstantinos Tsitsikas, Vassilios Papadakis,
George Vassilopoulos, and Sophia Polychronopoulou
87
MLL Rearrangements in Childhood Acute Lymphoblastic Leukemia:
Clinical and Genetic Features of a Distinct Disease Entity
Μ.Αmpatzidou, S.I.Papadhimitriou, L.Petrikkos, D.Pavlidis, Κ.Tsitsikas,
V.Papadakis, G.Paterakis and S.Polychronopoulou
20th Congress of European Hematology Association (EHA), Austria,
Vienna, 11 - 14 June 2015, με την ανακοίνωση:
88
VENOUS THROMBOEMBOLISM (VTE) IN CHILDREN WITH CANCER
AND HEMATOLOGICAL DISORDERS; 16 YEARS OF EXPERIENCE IN
A GREEK CENTER (Abstract: PB2053, publication only)
Maria Ampatzidou, Helen Pergantou, Helen Platokouki, Helen
Papachristodoulou, Vassilios Dendrinos, Efthymia Rigatou, Loizos
Petrikkos, Vassilios Papadakis, Sophia Polychronopoulou
20th ICAAC/ICC 2015 (Interscience Conference of Antimicrobial
Agents
and
Chemotherapy
-
International
Congress
of
Chemotherapy and Infection), San Diego, CA, September 17–21,
2015, με την ανακοίνωση:
89
Voriconazole
Prophylaxis
in
Children
with
Malignancies:
A
Nationwide Study
Z. Pana, M. Kourti, M. Papageorgiou, D. Doganis, M. Vlaxou, N.
Katzilakis, A. Kattamis, L.Petrikkos, E. Stiakaki, D. Koliouskas, M.
Chatzistilianou, S. Polychronopoulou, H. Kosmidis, S. Grafakos, E.
Roilides